Stany Zjednoczone - angielski - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - buprenorphine (unii: 40d3scr4gz) (buprenorphine - unii:40d3scr4gz) - buprenorphine 5 ug in 1 h - buprenorphine transdermal system is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. limitations of use - because of the risks of addiction, abuse and misuse with opioids, even at recommended doses, and because of the greater risk of overdose and death with extended-release opioid formulations [see warnings and precautions (5.1)] , reserve buprenorphine transdermal system for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. - buprenorphine transdermal system is not indicated as an as-needed (prn) analgesic. buprenorphine transdermal system is contraindicated in patients with: - significant respiratory depression [see warnings and precautions (5.2) ] - acute or severe bronchial asthma in an unmonitored setting or in t

Francja - angielski - HMA (Heads of Medicines Agencies)

dechra limited - buprenorphine 0.3 mg/ml - solution for injection - cats non food, dogs non food, horses non food - buprenorphine

Austria - angielski - HMA (Heads of Medicines Agencies)

dechra limited - buprenorphine 0.3 mg/ml - solution for injection - cats non food, dogs non food, horses non food - buprenorphine

Hiszpania - angielski - HMA (Heads of Medicines Agencies)

dechra limited - buprenorphine 0.3 mg/ml - solution for injection - cats non food, dogs non food, horses non food - buprenorphine

Węgry - angielski - HMA (Heads of Medicines Agencies)

dechra limited - buprenorphine 0.3 mg/ml - solution for injection - cats non food, dogs non food, horses non food - buprenorphine

Włochy - angielski - HMA (Heads of Medicines Agencies)

dechra limited - buprenorphine 0.3 mg/ml - solution for injection - cats non food, dogs non food, horses non food - buprenorphine

Holandia - angielski - HMA (Heads of Medicines Agencies)

dechra limited - buprenorphine 0.3 mg/ml - solution for injection - cats non food, dogs non food, horses non food - buprenorphine

Portugalia - angielski - HMA (Heads of Medicines Agencies)

dechra limited - buprenorphine 0.3 mg/ml - solution for injection - cats non food, dogs non food, horses non food - buprenorphine

Wielka Brytania - angielski - HMA (Heads of Medicines Agencies)

dechra limited - buprenorphine 0.3 mg/ml - solution for injection - cats non food, dogs non food, horses non food - buprenorphine

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

bryant ranch prepack - buprenorphine hydrochloride (unii: 56w8mw3en1) (buprenorphine - unii:40d3scr4gz) - buprenorphine 2 mg - buprenorphine sublingual tablets are indicated for the treatment of opioid dependence and is preferred for induction. buprenorphine sublingual tablets should be used as part of a complete treatment plan to include counseling and psychosocial support. buprenorphine sublingual tablets are contraindicated in patients with a history of hypersensitivity to buprenorphine, as serious adverse reactions, including anaphylactic shock, have been reported [see warnings and precautions  ( 5.9 ) ] . risk summary the data on use of buprenorphine, the active ingredient in buprenorphine sublingual tablets, in pregnancy, are limited; however, these data do not indicate an increased risk of major malformations specifically due to buprenorphine exposure. there are limited data from randomized clinical trials in women maintained on buprenorphine that were not designed appropriately to assess the risk of major malformations [see data] . observational studies have reported on congenital malformations among buprenorphine-exposed pre